These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9864551

  • 1. [Polycystic ovary syndrome: from physiopathology to therapy].
    Pugeat M.
    Ann Endocrinol (Paris); 1998 Nov; 59(4):305-9. PubMed ID: 9864551
    [No Abstract] [Full Text] [Related]

  • 2. Hirsutism and polycystic ovary syndrome.
    Givens JR, Goodman RC.
    Hosp Pract (Off Ed); 1986 Oct 30; 21(10A):81-4, 87-9, 93-4 passim. PubMed ID: 3095345
    [No Abstract] [Full Text] [Related]

  • 3. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr 30; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 4. Understanding the polycystic ovary syndrome.
    Givens JR, Kurtz BR.
    Prog Clin Biol Res; 1986 Apr 30; 225():355-76. PubMed ID: 3097672
    [No Abstract] [Full Text] [Related]

  • 5. The polycystic ovary syndrome. 1. Pathogenesis.
    White MC, Turner EI.
    Br J Hosp Med; 1986 Apr 30; 51(4):167-74. PubMed ID: 8012678
    [Abstract] [Full Text] [Related]

  • 6. [Somatomedin and somatostatin in polycystic ovary syndrome].
    Huber JC.
    Gynakol Rundsch; 1991 Apr 30; 31 Suppl 2():66-8. PubMed ID: 1686431
    [No Abstract] [Full Text] [Related]

  • 7. Serum Fetuin-A levels, insulin resistance and oxidative stress in women with polycystic ovary syndrome.
    Enli Y, Fenkci SM, Fenkci V, Oztekin O.
    Gynecol Endocrinol; 2013 Dec 30; 29(12):1036-9. PubMed ID: 23961784
    [Abstract] [Full Text] [Related]

  • 8. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug 30; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis and treatment of polycystic ovary disease.
    Hutchinson-Williams KA, DeCherney AH.
    Int J Fertil; 1987 Aug 30; 32(6):421-30. PubMed ID: 2891628
    [No Abstract] [Full Text] [Related]

  • 10. The polycystic ovary syndrome.
    Yen SS.
    Clin Endocrinol (Oxf); 1980 Feb 30; 12(2):177-207. PubMed ID: 6772357
    [No Abstract] [Full Text] [Related]

  • 11. The impact of insulin resistance on the outcome of laparoscopic ovarian diathermy in women with polycystic ovarian syndrome.
    Amer S, Li TC, Samuelson C, Ledger W.
    Acta Obstet Gynecol Scand; 2011 Apr 30; 90(4):338-43. PubMed ID: 21306324
    [Abstract] [Full Text] [Related]

  • 12. Polycystic ovary syndrome.
    Chihal HJ, Baudier MM.
    Am Fam Physician; 1985 Apr 30; 31(4):159-65. PubMed ID: 3157301
    [Abstract] [Full Text] [Related]

  • 13. [Physiopathology and therapy of polycystic ovary syndrome].
    Mihashi N, Kuwahara Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Aug 30; 47(8):814-23. PubMed ID: 7594891
    [No Abstract] [Full Text] [Related]

  • 14. Pathogenesis of polycystic ovarian disease.
    James R, Givens MD.
    Acta Eur Fertil; 1979 Sep 30; 10(3):89-103. PubMed ID: 121017
    [No Abstract] [Full Text] [Related]

  • 15. [Studies on mechanism of polycystic ovary syndrome and the diagnosis and treatment princial for adolescents].
    Gong CX, Li YC, Wu D.
    Zhonghua Er Ke Za Zhi; 2012 Jun 30; 50(6):425-8. PubMed ID: 22931938
    [No Abstract] [Full Text] [Related]

  • 16. [Current patholophysiologic and morphologic concepts of polycystic disease of the ovary].
    Vulkov I, Georgiev Ch.
    Akush Ginekol (Sofiia); 1982 Jun 30; 21(3):238-43. PubMed ID: 6289691
    [No Abstract] [Full Text] [Related]

  • 17. [Endocrine effects of laser vaporization of the ovaries in women with polycystic ovary syndrome].
    Rossmanith WG, Keckstein J, Spatzier K, Lauritzen C.
    Gynakol Rundsch; 1991 Jun 30; 31 Suppl 2():333-5. PubMed ID: 1790971
    [No Abstract] [Full Text] [Related]

  • 18. [The incidence of polycystic ovaries as a cause of sterility].
    Rosen A, Klein M, Beck A.
    Gynakol Rundsch; 1988 Jun 30; 28 Suppl 2():207-8. PubMed ID: 3148503
    [No Abstract] [Full Text] [Related]

  • 19. Polycystic ovaries: pathophysiology.
    Ahmed AS.
    J R Soc Promot Health; 2003 Jun 30; 123(2):78. PubMed ID: 12852187
    [No Abstract] [Full Text] [Related]

  • 20. Differential insulin response to myo-inositol administration in obese polycystic ovary syndrome patients.
    Genazzani AD, Prati A, Santagni S, Ricchieri F, Chierchia E, Rattighieri E, Campedelli A, Simoncini T, Artini PG.
    Gynecol Endocrinol; 2012 Dec 30; 28(12):969-73. PubMed ID: 22612517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.